18 related articles for article (PubMed ID: 16259946)
1. In vivo bioluminescence tumor imaging of RGD peptide-modified adenoviral vector encoding firefly luciferase reporter gene.
Niu G; Xiong Z; Cheng Z; Cai W; Gambhir SS; Xing L; Chen X
Mol Imaging Biol; 2007; 9(3):126-34. PubMed ID: 17297551
[TBL] [Abstract][Full Text] [Related]
2. Using Cystine Knot Proteins as a Novel Approach to Retarget Oncolytic Measles Virus.
Lal S; Raffel C
Mol Ther Oncolytics; 2017 Dec; 7():57-66. PubMed ID: 29367943
[TBL] [Abstract][Full Text] [Related]
3. Development of viral vectors for use in cardiovascular gene therapy.
Williams PD; Ranjzad P; Kakar SJ; Kingston PA
Viruses; 2010 Feb; 2(2):334-371. PubMed ID: 21994642
[TBL] [Abstract][Full Text] [Related]
4. Intravascularly administered RGD-displaying measles viruses bind to and infect neovessel endothelial cells in vivo.
Ong HT; Trejo TR; Pham LD; Oberg AL; Russell SJ; Peng KW
Mol Ther; 2009 Jun; 17(6):1012-21. PubMed ID: 19277014
[TBL] [Abstract][Full Text] [Related]
5. Enhanced gene transfer to rabbit jugular veins by an adenovirus containing a cyclic RGD motif in the HI loop of the fiber knob.
Hay CM; De Leon H; Jafari JD; Jakubczak JL; Mech CA; Hallenbeck PL; Powell SK; Liau G; Stevenson SC
J Vasc Res; 2001; 38(4):315-23. PubMed ID: 11455202
[TBL] [Abstract][Full Text] [Related]
6. CAR- or alphav integrin-binding ablated adenovirus vectors, but not fiber-modified vectors containing RGD peptide, do not change the systemic gene transfer properties in mice.
Mizuguchi H; Koizumi N; Hosono T; Ishii-Watabe A; Uchida E; Utoguchi N; Watanabe Y; Hayakawa T
Gene Ther; 2002 Jun; 9(12):769-76. PubMed ID: 12040458
[TBL] [Abstract][Full Text] [Related]
7. Fetal muscle gene transfer is not enhanced by an RGD capsid modification to high-capacity adenoviral vectors.
Bilbao R; Reay DP; Hughes T; Biermann V; Volpers C; Goldberg L; Bergelson J; Kochanek S; Clemens PR
Gene Ther; 2003 Oct; 10(21):1821-9. PubMed ID: 12960972
[TBL] [Abstract][Full Text] [Related]
8. Targeting adenoviral vectors by using the extracellular domain of the coxsackie-adenovirus receptor: improved potency via trimerization.
Kim J; Smith T; Idamakanti N; Mulgrew K; Kaloss M; Kylefjord H; Ryan PC; Kaleko M; Stevenson SC
J Virol; 2002 Feb; 76(4):1892-903. PubMed ID: 11799184
[TBL] [Abstract][Full Text] [Related]
9. Generation of fiber-modified adenovirus vectors containing heterologous peptides in both the HI loop and C terminus of the fiber knob.
Koizumi N; Mizuguchi H; Utoguchi N; Watanabe Y; Hayakawa T
J Gene Med; 2003 Apr; 5(4):267-76. PubMed ID: 12692861
[TBL] [Abstract][Full Text] [Related]
10. Efficient targeting of adenoviral vectors to integrin positive vascular cells utilizing a CAR-cyclic RGD linker protein.
Krom YD; Gras JC; Frants RR; Havekes LM; van Berkel TJ; Biessen EA; van Dijk KW
Biochem Biophys Res Commun; 2005 Dec; 338(2):847-54. PubMed ID: 16259946
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
